Search

Your search keyword '"Dacryocystitis metabolism"' showing total 66 results

Search Constraints

Start Over You searched for: Descriptor "Dacryocystitis metabolism" Remove constraint Descriptor: "Dacryocystitis metabolism"
66 results on '"Dacryocystitis metabolism"'

Search Results

1. AS101 regulates the Teff/Treg balance to alleviate rabbit autoimmune dacryoadenitis through modulating NFATc2.

2. Thymosin β4 Alleviates Autoimmune Dacryoadenitis via Suppressing Th17 Cell Response.

3. Marginal Zone B (MZB) Cells: Comparison of the Initial Identification of Immune Activity Leading to Dacryoadenitis and Sialadenitis in Experimental Sjögren's Syndrome.

4. The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis.

5. Heterochronic Parabiosis Causes Dacryoadenitis in Young Lacrimal Glands.

6. Altered Prostaglandin E Receptor Subtype 3 Expression in Lacrimal Glands of Patients with Chronic Stevens-Johnson Syndrome.

7. Toll-Like Receptor Signaling in the Pathogenesis of Chronic Dacryocystitis: Implication of c-FOS Transcription Factor and its Downstream Effector Chemokine Genes CCL2, CCL4, CXCL3, CXCR4 with a Shift of the M1/M2 Macrophage Phenotype.

8. MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs via miR-100-5p.

9. PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice.

10. The FcεRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.

11. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.

12. Programmed Cell Death-1 Pathway Deficiency Enhances Autoimmunity Leading to Dacryoadenitis of Mice.

13. A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland Dysfunction.

14. HIF1α-mediated TRAIL Expression Regulates Lacrimal Gland Inflammation in Dry Eye Disease.

15. Light chain amyloidosis of the lacrimal glands in a patient with chronic dacryoadenitis.

16. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.

17. Surfactant proteins: Role in lacrimal drainage disorders.

18. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.

19. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.

20. The Imbalance of Lymphocyte Subsets and Cytokines: Potential Immunologic Insights Into the Pathogenesis of Chronic Dacryocystitis.

21. Immunostaining of Immunoglobulin G4 in the Lacrimal Sac.

22. Essential role of CCL21 in establishment of central self-tolerance in T cells.

23. Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.

24. Changes in Tear Film Characteristics in Patients With Idiopathic Dacryoadenitis.

25. The pathological features of ectopic lymphoid neogenesis in idiopathic dacryoadenitis.

26. Acute dacryocystitis as a presenting sign of chronic lymphocytic leukaemia.

27. Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.

28. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

29. ENaC in the Rabbit Lacrimal Gland and its Changes During Sjögren Syndrome and Pregnancy.

30. Cytoplasmic and nuclear leptin expression in lacrimal gland tumours: a pilot study.

31. Does estrogen deficiency cause lacrimal gland inflammation and aqueous-deficient dry eye in mice?

32. Solitary fibrous tumour of the lacrimal sac presenting with recurrent dacryocystitis.

33. T helper subsets in Sjögren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review.

34. Ocular surface disease and dacryoadenitis in aging C57BL/6 mice.

35. Neutralization of ocular surface TNF-α reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye.

36. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren's syndrome-associated dry eye.

37. Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

38. Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.

39. Histopathology and immunohistochemical profile in idiopathic dacryoadenitis.

40. Changes of chloride channels in the lacrimal glands of a rabbit model of Sjögren syndrome.

41. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease.

42. Etiology of tearing: a retrospective analysis of referrals to a tertiary care oculoplastics practice.

43. Strong expression of HSP47 in metaplastic nasal mucosa may predict a poor outcome after primary endoscopic dacryocystorhinostomy: a prospective study.

44. Na(+)/K(+)-ATPase in the lacrimal glands of rabbits and its changes during induced autoimmune dacryoadenitis.

45. Expression of interleukin-17 in autoimmune dacryoadenitis in MRL/lpr mice.

46. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.

47. A case of immunoglobulin G4-related chronic sclerosing sialadenitis and dacryoadenitis associated with tuberculosis.

48. Mechanisms of murine lacrimal gland repair after experimentally induced inflammation.

49. Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice.

50. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.

Catalog

Books, media, physical & digital resources